Vincent Michael Chiodo, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 104 Tilghman Dr, Dunn, NC 28334 Phone: 910-892-1333 Fax: 910-892-2929 |
Dr. Marsha Yolanda Russell, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 802 Tilghman Dr, Dunn, NC 28334 Phone: 910-892-4248 Fax: 910-892-4461 |
Dr. Beverly A Yearwood, M.D Pediatrics Medicare: Medicare Enrolled Practice Location: 802 Tilghman Dr, Dunn, NC 28334 Phone: 910-892-4248 |
Dr. Abigail W Durden, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 3331 Easy St, Dunn, NC 28334 Phone: 910-567-6194 Fax: 910-567-5342 |
Dr. Michael Waldemar Knudsen, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 802 Tilghman Dr, Dunn, NC 28334 Phone: 910-892-4248 Fax: 910-892-4461 |
Dr. Mary Ann Chiodo, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 104 Tilghman Dr, Dunn, NC 28334 Phone: 910-892-1333 Fax: 910-892-2929 |
News Archive
To enhance the visibility of organs as they are scanned with magnetic resonance imaging (MRI), patients are usually injected with a compound known as a contrast agent before going into the scanner. The most commonly used MRI contrast agents are based on the metal gadolinium; however, these metal compounds can be harmful for young children or people with kidney problems.
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Mercy Health Services has selected its ProVation MD software for gastroenterology procedure documentation and coding. The software will be deployed in the Institute for Digestive Health and Liver Disease at Mercy.
EyeTechCare SA, which develops non-invasive therapeutic medical devices for the ophthalmology market based on the use of ultrasound, today announces that its EyeOP1 device is to be installed in a number of hospitals in France, namely Lille University Hospital, Grenoble University Hospital and the Quinze-Vingts and Saint-Joseph hospitals in Paris. The first use of this device for the routine treatment of glaucoma patients is slated from July onwards.
The use of chemotherapy following surgery reduces the risk of death from operable pancreatic cancer by around 30 per cent, says new research published in the British Journal of Cancer.
› Verified 3 days ago